For example, decreased eNOS expression in end‐stage PAH lungs may be real, but data regarding eNOS including its expression and functional roles (e.g., hemodynamic effects of NOS inhibition) at the time of diagnosis when they matter most are extremely limited. This evidence concerns the gene NOS3 and pulmonary arterial hypertension.